Published in Lupus on November 02, 2009
Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011. Arthritis Care Res (Hoboken) (2015) 0.89
Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan. Arch Med Sci (2012) 0.84
National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. PLoS One (2016) 0.81
Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study. BMC Musculoskelet Disord (2015) 0.75
Healthcare-associated infections in rheumatology in Japan. Rheumatol Int (2011) 0.75
Incidence and risk of infection in egyptian patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord (2014) 0.75
Infections and systemic lupus erythematosus. Einstein (Sao Paulo) (2016) 0.75
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol (1999) 2.62
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 2.27
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2009) 1.42
Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis (2001) 1.25
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Features of spondyloarthritis around the world. Rheum Dis Clin North Am (1998) 1.13
Validation of a Spanish version of the Childhood Health Assessment Questionnaire. J Rheumatol (1997) 1.11
Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis (2005) 1.09
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis (2002) 1.03
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis (2006) 1.02
Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (2006) 1.02
Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.99
Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol (1998) 0.98
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
Intradermal tophi in gout: a case-control study. J Rheumatol (1999) 0.97
Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis Rheum (1999) 0.97
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis (2002) 0.93
Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) (2001) 0.90
The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis (1997) 0.88
TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin Exp Rheumatol (2002) 0.88
Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol (1995) 0.88
Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum (2009) 0.87
Severe tophaceous gout. Characterization of low socioeconomic level patients from México. Clin Exp Rheumatol (2006) 0.87
Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) (2000) 0.87
HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol (2005) 0.86
Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol (2014) 0.85
Update on functional assessment tools. J Rheumatol Suppl (2000) 0.84
Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2006) 0.83
HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol (1997) 0.83
Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients. Clin Exp Rheumatol (2009) 0.83
Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol (1995) 0.82
Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol (1997) 0.82
Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol (2000) 0.81
Antibodies to peptidoglycan in juvenile onset ankylosing spondylitis and pauciarticular onset juvenile arthritis associated with chronic iridocyclitis. J Rheumatol (1986) 0.81
[Juvenile ankylosing spondylitis: clinical characteristics in 41 patients]. Bol Med Hosp Infant Mex (1985) 0.81
The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol (2010) 0.80
IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients. Scand J Rheumatol (2002) 0.80
Association of HLA DRB1 alleles with juvenile idiopathic arthritis in Mexicans. Clin Exp Rheumatol (2010) 0.80
Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann Rheum Dis (2010) 0.80
Anterior spinal flexion in healthy Mexican children. J Rheumatol (1985) 0.79
Illness trajectories in Mexican children with juvenile idiopathic arthritis and their parents. Rheumatology (Oxford) (2006) 0.79
Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol (2009) 0.78
Antibody pattern and other criteria for diagnosis and classification in PSS. J Rheumatol (1988) 0.78
Assessment of quality of life in children with rheumatic disease. J Rheumatol (1999) 0.78
Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.78
The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 0.78
A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 0.77
[The qualitative approach in health: an alternative to clinical research in rheumatic diseases]. Reumatol Clin (2008) 0.77
Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid. J Clin Pathol (2007) 0.77
Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis (2004) 0.77
Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J Rheumatol (1998) 0.77
Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb Pathog (2000) 0.77
Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scand J Rheumatol (2010) 0.75
Novel concepts of severity mechanisms in ankylosing spondylitis. J Rheumatol (2001) 0.75
Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms. J Rheumatol (1988) 0.75
Uveitis of juvenile ankylosing spondylitis. J Rheumatol (1988) 0.75
[Recognition and diagnosis of juvenile ankylosing spondylitis: clinical analysis and comparative study of juvenile rheumatoid arthritis]. Bol Med Hosp Infant Mex (1988) 0.75
[Clinical study of dermato/polymyositis with onset in childhood]. Bol Med Hosp Infant Mex (1987) 0.75
[Effectiveness of biological agents in ankylosing spondylitis]. Reumatol Clin (2008) 0.75
[Axial involvement in juvenile ankylosing spondylitis]. Bol Med Hosp Infant Mex (1988) 0.75
[Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study]. Rev Invest Clin (1984) 0.75
Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase. Rev Latinoam Microbiol (1997) 0.75
Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases. Reumatol Clin (2008) 0.75
Systemic features and early prognostic factors in Hispanic and non-Hispanic children from the United States of America and Mexico with systemic juvenile idiopathic arthritis. Clin Exp Rheumatol (2008) 0.75
Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout. J Clin Rheumatol (2000) 0.75